Singapore, Sept. 18 -- US health tech company Massive Bio has appointed international business development consultancy Intralink to support its expansion into South Korea and build partnerships across the country's oncology sector.

Massive Bio provides an AI-powered platform that connects cancer patients with suitable clinical trials. The company works with global pharmaceutical companies, hospitals and oncologists to identify patients who meet the often highly specific requirements of oncology studies.

To date, Massive Bio has matched 200,000 patients with 19,000 clinical trials across 17 markets.

To support Massive Bio's expansion into South Korea, Intralink's Seoul team will build relationships with leading hospitals, diagnostic lab...